Retraction Statement: Predictive validity of a medication adherence measure in an outpatient setting( The Journal of Clinical Hypertension, (2008), 10, (348–354), 10.1111/j.1751-7176.2008.07572.x);Predictive validity of a medication adherence measure in an outpatient setting

Journal of Clinical Hypertension

Volumn 10, Issue 5, 2008, Pages 348-354

  Morisky, Donald E ^a   Ang, Alfonso ^b   Krousel Wood, Marie ^c,d   Ward, Harry J ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c OCHSNER CLINIC FOUNDATION   (United States)

^d TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^e Charles Drew Medical School   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADOLESCENT; ADULT; AMBULATORY CARE; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOCTOR PATIENT RELATION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MALE; METHODOLOGY; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION; PSYCHOMETRY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AMBULATORY CARE; ANTIHYPERTENSIVE AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PHYSICIAN-PATIENT RELATIONS; PSYCHOMETRICS; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 49349115364     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.14718     Document Type: Erratum

References (47)

1. Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007;49(1):69-75.
2. Krousel-Wood MA, Muntner P, He J, et al. Primary prevention of essential hypertension. Med Clin North Am. 2004;88:223-238.
3. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA. 2003;289:2560-2572.
4. DiMatteo MR, Giordani PJ, Lepper HS , et al. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40:794-811.
5. Krousel-Wood M, Thomas S, Muntner P, et al. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol. 2004;19:357-362.
6. Moser M, Franklin SFSF. Hypertension management: results of a new national survey for the Hypertension Education Foundation: Harris Interactive. J Clin Hypertens (Greenwich). 2007;9(5):316-323.
7. Hamilton GA. Measuring adherence in a hypertension clinical trial. Eur J Cardiovasc Nurs. 2003;2:219-228.
8. Wogen J, French F. Patient adherence with hypertension medication. J Manag Care Pharm. 2004;10:90-101.
9. Haynes RB, McDonald HP , Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA. 2002;288:2880-2883.
10. Ward HJ, Morisky DE, Lees NB, et al. A clinic and community-based approach to hypertension control for an underserved minority population: design and methods. Am J Hypertens. 2000;13:177-183.
11. Morisky DE, Lees NB, Sharif BA, et al. Reducing disparities in hypertension control: a community based Hypertension Control Project (CHIP ) for a low income minority population. Health Promot Pract. 2002;3:267-278.
12. Van Veen WA. Treatment adherence in hypertension: problems and research. J R Coll Gen Pract Occas Pap. 1980;12:22-25.
13. Stamler R, Stamler J, Civinelli J, et al. Adherence and blood-pressure response to hypertension treatment. Lancet. 1975;2:1227-1230.
14. Schoenberg NE. The relationship between perceptions of social support and adherence to dietary recommendations among African-American elders with hypertension. Int J Aging Hum Dev. 1998;47:279-297.
15. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self reported measure of medication adherence. Med Care. 1986;24:67-74.
16. Norman SA, Marconi KM, Schezel GW, et al. Beliefs, social normative influences, and compliance with anti-hypertensive medication. Am J Prev Med. 1985;1:10-17.
17. Klein LE. Compliance and blood pressure control. Hypertension. 1988;11:II 61-II 64.
18. Bittar N. Maintaining long-term control of blood pressure: the role of improved compliance. Clin Cardiol. 1995;18(6 suppl 3):12-16.
19. Svensson S, Kjellgren KI. Adverse events and patient's perceptions of antihypertensive drug effectiveness. J Hum Hypertens. 2003;17:671-675.
20. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297-333.
21. Boone KB, Ponton MO, Gorsuch RL, et al. Factor analysis of four measures of prefrontal lobe functioning. Arch Clin Neuropsychol. 1998;13:585-595.
22. Katz D, Foxman B. How well do prediction equations predict? Using receiver operating characteristic curves and accuracy curves to compare validity and generalizability. Epidemiology. 1993;4:319-326.
23. Fields LE, Burt VL, Cutler JA, et al. The burden of adult hypertension in the United States 1999 to 2000. Hypertension. 2004;44:398-404.
24. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217-223.
25. Monane M, Bohn RL, Gurwitz JH, et al. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Public Health. 1996;86:1805-1808.
26. Marentette MA, Gerth WC, Billings DK, et al. Antihypertensive persistence and drug class. Can J Cardiol. 2002;18:649-656.
27. Monane M, Bohn RL, Gurwitz JH, et al. A population-based study of compliance with antihypertensive therapy: role of age, gender and race. Am J Public Health. 1996;86:1805-1809.
28. Wang PS , Bohn RL, Knight E, et al. Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med. 2002;17:504-511.
29. Egan BM, Lackland DT, Cutler NE. Awareness, knowledge and attitudes of older Americans about high blood pressure. Arch Intern Med. 2003;163:681-687.
30. Iskedjian M, Einarson TRTR, MacKeigan LD, et al. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from meta-analysis. Clin Ther. 2002;24:302-316.
31. World Health Organization. Adherence to long-term therapies evidence for action. World Health Organization. 2003;107-114. http://www.who.int/bookorders/anglais/detart1.isp?sesslan=1&codlan=1&codcol=15&codcch-526. Accessed march 31, 2008.
32. Wassertheil-Smoller S, Blaufox MD, Oberman A, et al. Effect of antihypertensives on sexual function and quality of life: the TAIM Study. Ann Intern Med. 1991;114(8):613-620.
33. Gregoire JP, Moisan J, Guibert R, et al. Tolerability of antihypertensive drugs in a community-based setting. Clin Ther. 2001;23:715-726.
34. Krousel-Wood MA, Thomas S, Jannu A, et al. Low adherence to prescribed antihypertension medication and poorer quality of life in elderly hypertensive patients. Poster presented at: American Heart Association, 2nd Scientific Conference Compliance in Healthcare and Research, Washington, DC; May 18, 2004.
35. Wizner B, Gryglewska B, Gasowski J, et al. Normal blood pressure values as perceived by normotensive and hypertensive subjects. J Hum Hypertens. 2003;17:87-91.
36. Benson J, Britten N. Patients' views about taking antihypertensive drugs: questionnaire study. BMJ. 2003;326:1314-1315.
37. Ogedegbe G, Mancuso CA, Allegrante JP, et al. Development and evaluation of a medication adherence self-efficacy scale in hypertensive African-American patients. J Clin Epidemiol. 2003;56:520-529.
38. O'Connor PJ. Overcome clinical inertia to control systolic blood pressure. Arch Intern Med. 2003;163:2677-2678.
39. Christensen DB, Williams B, Goldberg HI , et al. Assessing compliance to antihypertensive medications using computer-based pharmacy records. Med Care. 1997;35:1164-1170.
40. Hawkshead J, Krousel-Wood MA. Techniques for measuring medication adherence in hypertensive patients in outpatient settings: advantages and limitations. Dis Manage Health Outcomes. 2007;15:109-118.
41. Bova CA, Fennie KP, Knafl GJ, et al. Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations. AIDS Behav. 2005;9:103-110.
42. Kim MT, Hill MN, Bone LR, et al. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Prog Cardiovasc Nurs. 2000;15(3):90-96.
43. Shea S, Misra D, Ehrlich MH, et al. Correlates of nonadherence to hypertension treatment in an inner-city minority population. Am J Public Health. 1992;82:1607-1612.
44. Harmon G, Lefante J, Krousel-Wood MA. Overcoming barriers: the role of providers in improving patient adherence to antihypertensive medications. Curr Opin Cardiol. 2006;21:310-315.
45. Moser M, Setaro JF. Clinical practice. Resistant or difficult-to-control hypertension. N Engl J Med. 2006;355(4):385-392.
46. Morisky DE, Levine DM, Green LW, et al. Five-year blood pressure control and mortality following health education for hypertensive patients. Am J Public Health. 1983;73:153-162.
47. Morisky DE, Malotte CK, Choi P, et al. A patient education program to improve adherence rate with antituberculosis drug regimens. Health Educ Q. 1990;17:253-268.